OS Therapies (NYSE:OSTX) Now Covered by Analysts at Maxim Group
Maxim Group assumed coverage on shares of OS Therapies (NYSE:OSTX – Free Report) in a report published on Tuesday,Benzinga reports. The brokerage issued a buy rating and a $8.00 price target on the ...
Dynamite News1 天
Study finds how cancer cells of fat may improve cancer treatment
"We want to make cancer treatment more effective," said Evan Lien, Ph.D., an assistant professor at VAI and the study's ...